Cited by 163Gut microbiota and healthClostridium difficile and Clostridium perfringens researchGastrointestinal motility and disorders

Fecal microbiota transplantation beyond Clostridioides difficile infections

Open access
Wortelboer, Koen, Nieuwdorp, Max, Herrema, Hilde·2019·eBioMedicine

Abstract

The importance of the commensal microbiota to human health and well-being has become increasingly evident over the past decades. From a therapeutic perspective, the popularity of fecal microbiota transplantation (FMT) to restore a disrupted microbiota and amend imbalances has increased. To date, most clinical experience with FMT originates from the treatment of recurrent or refractory Clostridioides difficile infections (rCDI), with resolution rates up to 90%. In addition to CDI, a role for the intestinal microbiome has been implicated in several disorders. FMT has been tested in several randomized controlled trials for the treatment of inflammatory bowel disease, irritable bowel disease and constipation with mixed results. FMT has also been explored for extra-gastrointestinal disorders such as metabolic syndrome, hepatic encephalopathy and graft-versus-host disease. With the exception of recurrent CDI, FMT is currently used in experimental settings only and should not yet be offered as standard care. In addition, it is critical to further standardize and optimize procedures for FMT preparation. This includes determination of active components of FMT to develop (personalized) approaches to treat disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ebiom.2019.05.066

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Together with the rapidly growing utility of FMT for treating several other conditions in recent years, FMT offers the greatest immediate hope for producing clinically meaningful therapeutic modulation of the gut microbiome in prodromal and early PD.

    “Together with the rapidly growing utility of FMT for treating several other conditions in recent years [210, 211], FMT offers the greatest immediate hope for producing clinically meaningful therapeutic modulation of the gut microbiome in prodromal and early PD.”

    From The gut–brain axis in early Parkinson’s disease: from prodrome to prevention (2025) · cites this paper as [211]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [39]Costello S.P. Waters O. Bryant R.V. Katsikeros R. Makanyanga J. Schoeman M. Short duration, low intensity, pooled fecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial Gastroenterology 152 5 2017 (S198–9) Costello SP, Waters O, Bryant R V., Katsikeros R, Makanyanga J, Schoeman M, et al. Short Duration, Low Intensity, Pooled Fecal Microbiota Transplantation Induces Remission in Patients with Mild-Moderately Active Ulcerative Colitis: A Randomised Controlled Trial. Gastroenterology. 2017;152(5):S198–9.

Cited by

Sorted by citations

Authors
Wortelboer, K., Nieuwdorp, M., & Herrema, H.
Affiliations
Amsterdam UMC Location University of Amsterdam (NL)
Corresponding author
Wortelboer, Koen
Venue
eBioMedicine
Publisher
Elsevier BV
Published
2019-06
Volume
44
Pages
716-729
ISSN
2352-3964 (ISSN-L)
OpenAlex
W2951800528
Cited by
163
References
101
Citations by year
2026: 12 · 2025: 24 · 2024: 29 · 2023: 24 · 2022: 24 · 2021: 27 · 2020: 16 · 2019: 7
FWCI
1.66
Type
journal article
Language
en
Open access
Locations
  • EBioMedicine (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Novo Nordisk Fonden (2018)
  • ZonMw
  • Hartstichting
  • Fondation Leducq
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
fecal microbiota transplantation, Clostridium difficile infection, gut microbiota, inflammatory bowel disease, irritable bowel syndrome, constipation, metabolic syndrome, hepatic encephalopathy, graft-versus-host disease
MeSH terms
Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Animals, Mental Disorders, Clostridium Infections, Gastrointestinal Diseases, Humans, Immune System Diseases, Metabolic Diseases, Nervous System Diseases, Clostridioides difficile

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review